Role Description
UnitedHealthcare is seeking an experienced oncology pharmacist to serve as a clinical and strategic leader for oncology medications across the medical and pharmacy benefits. This role will shape clinically sound, operationally feasible, and affordable coverage strategies while protecting appropriate member access and supporting providers, customers, and enterprise partners.
The Senior Clinical Pharmacist will be a primary pharmacy subject matter expert for the oncology portfolio, including:
-
Cancer Guidance Program
-
Oncology clinical policies and pathways
-
Prescription Drug List (PDL) and preferred-product strategies
-
Utilization management
-
Site-of-care optimization
-
Medical drug exclusions
-
Biosimilars
-
Dose optimization
-
Emerging therapies
The pharmacist will translate rapidly evolving oncology evidence into practical coverage, program, and affordability recommendations and will help move those recommendations through governance and implementation.
Youβll enjoy the flexibility to work remotely from anywhere within the U.S. as you take on some tough challenges.
Qualifications
-
Doctor of Pharmacy degree
-
Active, unrestricted pharmacist license in at least one U.S. jurisdiction
-
Board Certified Oncology Pharmacist (BCOP)
-
2+ years of progressive oncology pharmacy experience in direct patient care, managed care, health plan, PBM, oncology pathways, medical benefit management, specialty pharmacy, pharmaceutical industry, or a closely related setting
-
Experience presenting complex clinical recommendations to multidisciplinary committees or senior stakeholders
-
Demonstrated solid written, verbal, analytical, project leadership, and relationship-management skills
-
Demonstrated ability to critically evaluate oncology literature, guidelines, compendia, clinical pathways, treatment sequencing, supportive care, and emerging therapies
Requirements
-
Postgraduate residency training, preferably PGY1 plus PGY2 oncology, or equivalent advanced oncology practice experience
-
Experience within a national or regional health plan, PBM, medical benefit manager, oncology pathway organization, integrated delivery network, or large oncology practice
-
Experience developing, interpreting, or operationalizing oncology coverage policies, prior authorization criteria, pathways, formularies, or utilization-management programs
-
Experience with oncology site-of-care programs, biosimilars, dose rounding or banding, duration management, therapeutic or medical drug exclusions, and preferred-product strategies
-
Experience using claims, utilization, market-share, and financial analyses to develop and monitor affordability initiatives
-
Experience engaging providers, employers, brokers, consultants, manufacturers, or external clinical stakeholders
-
Experience leading complex, cross-functional initiatives in a matrixed organization; formal people leadership or mentoring experience is a plus
-
Working knowledge of medical and pharmacy benefit design, HCPCS/J-codes and NDCs, buy-and-bill, white-bagging or alternate sourcing models, specialty pharmacy, provider reimbursement, and oncology network considerations
Benefits
-
Comprehensive benefits package
-
Incentive and recognition programs
-
Equity stock purchase
-
401k contribution (all benefits are subject to eligibility requirements)
Core Competencies
-
Oncology expertise and clinical judgment: Applies current evidence while recognizing patient heterogeneity, sequencing complexity, and operational realities
-
Strategic and financial acumen: Connects clinical decisions to trend, affordability, provider economics, and business objectives without compromising clinical defensibility
-
Execution discipline: Moves recommendations from concept through governance, implementation, communication, and performance monitoring
-
Influence and collaboration: Builds alignment across medical, pharmacy, operations, network, finance, legal, and customer-facing teams
-
Communication: Makes complex oncology topics understandable and actionable for clinical and non-clinical audiences
-
Innovation and continuous improvement: Identifies scalable solutions, questions legacy processes, and anticipates the implications of a rapidly changing oncology market